Observational study / 2013
In male smokers, higher coffee intake was linked to lower risks of incident liver cancer and chronic liver disease mortality.
Researchers examined the association between coffee intake and liver disease in 27,037 Finnish male smokers followed for up to 24 years. Coffee intake was inversely associated with incident liver cancer (RR per cup per day = 0.82, 95% CI: 0.73-0.93; P-trend across categories = 0.0007) and mortality from chronic liver disease (RR = 0.55, 95% CI: 0.48-0.63; P-trend < 0.0001). Inverse associations persisted in those without diabetes, HBV- and HCV-negative cases, across strata of age, body mass index, alcohol, and smoking dose, and for both boiled and filtered coffee.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 27,037 Finnish male smokers, aged 50-69, in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
- What was measured
- Incident liver cancer and chronic liver disease mortality over up to 24 years of follow-up
THE PAPER
The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers.
Lai GY, Weinstein SJ, Albanes D, Taylor PR, McGlynn KA, Virtamo J, Sinha R, Freedman ND. Br J Cancer, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.